Who are we?

We are a multi-disciplinary international team of globally renown and award-winning industry leaders in: 

Machine learning
Artificial intelligence
Data science
Computational biology
Bioinformatics, and 

Global commercial track record in medical science and artificial intelligence

4 previous startups, with 3 exits (including to Raytheon) and one remaining venture, currently active in over 42 countries across 4 continents.

Selection of international keynote addresses in medical science and artificial intelligence

The United Nations (New York) 
Harvard University (Boston)
The Credit Suisse Global Investment Forum (Singapore)
Columbia University (New York)
The World Health Organisation (New York)
Yale University (Connecticut)
The Royal Geographical Society (London)
The Aspen Institute (Aspen)
NHS Trust – Chelsea & Westminster (London)
The Zurich Family Office Investment Forum (Switzerland)
Wellcome Trust (London)
Infectious Disease Society of America (Washington DC)
Johns Hopkins Bloomberg School of Public Health (Baltimore)
USAID (Washington DC)
TBLI Europe (Amsterdam)
The American Academy of Paediatrics (New York)
The International Finance Corporation IFC (Washington)
The Asian Private Equity & Venture Capital Association Annual Conference (Singapore)
ASHOKA (Washington DC) 
PATH (Seattle)
The University of California (UCSF) – (San Francisco)
The House of Lords – Private Session (London)
The University of California (UCLA) – (Los Angeles)
The Albert Einstein College of Medicine (New York)
The American Society for Tropical Medicine and Hygiene (San Francisco)
Skoll World Forum (Oxford University)
Cornell University (New York)
Johnson & Johnson (US)
Wellcome Trust (London)
Brown University (Rhode Island)
JP Morgan Chase (New York)
TBLI Nordic (Oslo)
The Geneva Health Forum (Geneva)
PEPFAR (Washington DC)
The Aspen Institute Global Health Forum (Aspen)
The London School of Tropical Medicine & Hygiene (London)
The University of Southern California (California)
The Global Health Council (Washington DC)
Duke University (Durham)
Follow The Entrepreneur Summit (London)
and many others.

Selection of past commercial clients and partners in medical science and artificial intelligence

Bristol Myers Squibb
Merck & Co
McKinsey & Co
US Department of Justice
International Finance Corporation (IFC)
Johnson & Johnson
Morgan Stanley
Centers For Disease Control (CDC)
Heineken Breweries
JP Morgan
Anglo Gold 
Standard Chartered
Anglo American 
Pratt & Whitney 
GE Aviation
Deutsche Bahn 
Canadian Pacific
San Francisco County
Dallas County
and many others.

Global media coverage includes

NBC News (New York)
The American Journal of Medicine (USA)
The BBC (London)
PBS Television Network – documentary (New York)
The Economist Magazine (London) 
The Huffington Post (New York)
Science Daily (Maryland)
The Boston Herald (Boston) 
Belane Magazine – multiple feature editions (Switzerland)
Carl Magazine – feature edition (London)
South China Morning Post – multiple feature editions (Hong Kong)
Singapore Business Times – Cover & Raffles Conversation feature (Singapore)
The New Humanitarians (USA)
Scottish TV News (UK)
Carl Asia Magazine – cover and multiple feature editions (Hong Kong)
Diversion Magazine (US)
One World Health (London)
York Daily Record  (York)
The University of Texas at Dallas (Dallas)
and many others.

Professional medical and global health associations

The Royal Society For Public Health
The Royal Society of Medicine 
The Royal College of Physicians
The Royal Society for Tropical Medicine & Hygiene
The Royal Geographical Society
Physicians for Social Responsibility
The American Public Health Association
Henry Crown Fellow The Aspen Institute, and 
The International Institute For Strategic Studies.

International governmental and public policy medical science and AI investment adjudication, representation and advisory

Official representative to the United Nations General Assembly in New York 
Representative to the United Nations in Geneva and Vienna
Consultative status to the United Nations Economic and Social Council 
Investment Judge for AI and healthcare investments for the $110 Bn European Commission’s Horizon Europe Investment Fund
Expert Evaluator for AI and healthcare investments at the European Innovation Council and SMEs Executive Agency (EISMEA), and
Expert Mentor for AI and medical/healthcare investment portfolio companies of the $10 Bn European Commission’s European Innovation Council Fund.

Academic publications

Over 100 academic publications in medical science and artificial intelligence (the majority being peer reviewed)